CIK 0000890821
- Non-accelerated filer
- Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954484725
- Phone
- +1 617-444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chairman, President, CEO, CFO bought 3,267,974 shares at $0.02 ($50,000)
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Returned to the company Director returned 2,334,516 shares (to the company)
- 4 Returned to the company Director returned 4,181,396 shares (to the company)
- 4 Open-market sale Chief Financial Officer sold 713,527 shares at $0.03 ($17,838)
- 4/A Open-market buy Chief Financial Officer bought 2,334,516 shares at $0.02 ($36,185)
- 4/A Open-market buy Chief Executive Officer bought 3,307,484 shares at $0.02 ($51,266)
- 4 Open-market buy Chief Executive Officer bought 0 shares
Page 11 of 12 · 234 filings